Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Treatment
Share your love
Pars Plana Vitrectomy (PPV) & Patients Education I OBN
Pars plana vitrectomy (PPV) is a surgical procedure introduced by Robert Machemer that provides access to the posterior segment of the eye, allowing for the treatment of various vitreoretinal diseases. This technique has revolutionized ophthalmic surgery by enabling the management…
AAOF & Meta Launch $1.5M Myopia Open-Science Initiative
The American Academy of Optometry Foundation (AAOF), in partnership with Meta Reality Labs, has launched a $1.5 million open-science research initiative to study the relationship between visual experience and the progression of myopia. This initiative will support three independent studies…
VSY Biotechnology Announces OSA 2024 Winners at ESCRS 2024
VSY Biotechnology GmbH, a global leader in ophthalmic innovation and research, proudly announced the winners of the prestigious Ophthalmology Star Awards 2024 (OSA) during the Satellite Symposium at the ESCRS 2024 Congress in Barcelona. The annual Ophthalmology Star Awards ceremony…
CHMP Upholds Negative Opinion on Apellis’ GA Treatment
Apellis Pharmaceuticals faced another challenge as the EMA’s Committee for Medicinal Products for Human Use (CHMP) upheld its negative opinion on pegcetacoplan, a treatment for geographic atrophy (GA). Despite strong support from the European retina community and dissenting votes from CHMP…
MCG Secures $1.5M Grant for New Diabetic Retinopathy Therapy
Researchers at the Medical College of Georgia (MCG) at Augusta University have been awarded a $1.5 million grant from the National Eye Institute to develop a new treatment for diabetic retinopathy, a leading cause of blindness. Diabetic retinopathy results from…
Prevent Blindness Launches Children’s Vision Health Map
Prevent Blindness has introduced the Children’s Vision Health Map, an online tool that highlights geographic variations in children’s vision issues, visual impairment, and blindness across the U.S. The tool uses data from the CDC’s Vision and Eye Health Surveillance System…
Trinity College Develops Gene Therapy for Glaucoma and AMD
A team of researchers at Trinity College Dublin has developed a gene therapy that shows promise for treating both glaucoma and dry age-related macular degeneration (AMD). The therapy, which uses an enhanced gene (eNdi1) delivered by an approved virus, aims…
Visionix Unveils VX 610 Fundus Camera for DR Screening
Visionix USA has introduced the VX 610, a non-mydriatic automated fundus camera designed to improve retinal imaging and diabetic retinopathy screening. The VX 610 features auto alignment, auto focus, and auto capture, allowing for consistent, high-quality imaging with minimal user…
Opus Genetics Receives FDA RPD Designation for OPGx-LCA5
Research Triangle Park, N.C. – August 20, 2024 – Opus Genetics has announced that the U.S. Food and Drug Administration (FDA) has granted Rare Pediatric Disease (RPD) designation for its ocular gene therapy, OPGx-LCA5, which aims to treat patients with…
Sandoz Receives FDA Approval for ENZEEVU™
Sandoz has secured FDA approval for ENZEEVU™ (aflibercept-abzv), a biosimilar to EYLEA®, to treat retinal conditions like wet age-related macular degeneration (AMD) and diabetic retinopathy. This approval strengthens Sandoz’s U.S. biosimilar portfolio, offering a cost-effective alternative for managing retinal diseases.…